BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 7:22:00 PM | Browse: 1071 | Download: 956
Publication Name World Journal of Hepatology
Manuscript ID 6662
Country Spain
Received
2013-10-31 18:29
Peer-Review Started
2013-11-14 23:34
To Make the First Decision
2013-12-25 18:08
Return for Revision
2013-12-26 10:31
Revised
2014-01-09 01:05
Second Decision
2014-04-03 10:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-03 10:58
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-05-08 20:32
Publish the Manuscript Online
2014-05-20 15:05
ISSN 1948-5182 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease
Manuscript Source Invited Manuscript
All Author List Agustin Castiella, Eva Zapata, M Isabel Lucena and Raúl J Andrade
Funding Agency and Grant Number
Corresponding Author Agustin Castiella, PhD, MD, Gastroenterology Service, Mendaro Hospital, Barrio Mendarozabal, 20850 Mendaro, Spain. agustincastiella@yahoo.es
Key Words Drug-induced liver injury; Autoimmune hepatitis; Drugs; Drug-induced autoimmune hepatitis; Drug-induced autoimmune liver disease
Core Tip Drug-induced autoimmune liver disease (DIAILD) is a poorly defined and under-reported liver disorder, and, probably, a underestimated liver disease. A small number of drug-induced liver injury (DILI) cases exhibit features typical of autoimmune hepatitis (AIH). To differentiate between true AIH triggered by drugs (DI-AIH) and immune mediated DILI still remains a challenge. Patients diagnosed with DIAILD have frequently had a previous episode of hepatotoxicity. We consider that some basic requirements are needed to be considered before supporting a drug as a trigger of AIH and they should be taken into account by authors, reviewers and editors when cases are published and made available to the scientific community.
Publish Date 2014-05-20 15:05
Citation Castiella A, Zapata E, Lucena MI, Andrade RJ. drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease. World J Hepatol 2014; 6(4): 160-168
URL http://www.wjgnet.com/1948-5182/full/v6/i4/160.htm
DOI http://dx.doi.org/10.4254/wjh.v6.i4.160
Full Article (PDF) WJH-6-160.pdf
Full Article (Word) WJH-6-160.doc
Manuscript File 6662-Review.doc
Answering Reviewers 6662-Answering reviewers.pdf
Copyright License Agreement 6662-Copyright assignment.pdf
Peer-review Report 6662-Peer review(s).pdf
Scientific Editor Work List 6662-Scientific editor work list.doc